{"id":"https://openalex.org/W2032653796","doi":"https://doi.org/10.1016/j.bmcl.2012.10.066","title":"Discovery of a novel series of 4-quinolone JNK inhibitors","display_name":"Discovery of a novel series of 4-quinolone JNK inhibitors","publication_year":2012,"publication_date":"2012-10-24","ids":{"openalex":"https://openalex.org/W2032653796","doi":"https://doi.org/10.1016/j.bmcl.2012.10.066","mag":"2032653796","pmid":"https://pubmed.ncbi.nlm.nih.gov/23142618"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2012.10.066","doi":"https://doi.org/10.1016/j.bmcl.2012.10.066","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.066","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082243309","display_name":"Leyi Gong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leyi Gong","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA. leyi.gong@sri.com","Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA. leyi.gong@sri.com","institution_ids":["https://openalex.org/I129302853"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061163519","display_name":"Yun-Chou Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun-Chou Tan","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036999938","display_name":"Genevi\u00e8ve N. Boice","orcid":"https://orcid.org/0000-0002-3083-6162","observed_orcids":["https://orcid.org/0000-0002-3083-6162"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Genevieve Boice","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011102489","display_name":"Sarah C. Abbot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Abbot","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025096292","display_name":"Kristen L. McCaleb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen McCaleb","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026468998","display_name":"Pravin S. Iyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pravin Iyer","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033267422","display_name":"Fengrong Zuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fengrong Zuo","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073869421","display_name":"Joseph Dal Porto","orcid":"https://orcid.org/0009-0003-7520-1018","observed_orcids":["https://orcid.org/0009-0003-7520-1018"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Dal Porto","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Wong","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018930100","display_name":"Sue Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sue Jin","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012483729","display_name":"Alice Y. Chang","orcid":"https://orcid.org/0000-0001-7108-0499","observed_orcids":["https://orcid.org/0000-0001-7108-0499"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Chang","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074182290","display_name":"Patricia Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Tran","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057261683","display_name":"Gary Hsieh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Hsieh","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011096203","display_name":"Linghao Niu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linghao Niu","raw_affiliation_strings":["Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation Therapeutic Area, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110166955","display_name":"A. Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ada Shao","raw_affiliation_strings":["Department of Discovery Technologies, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Technologies, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029964264","display_name":"Deborah C. Reuter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Reuter","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088274519","display_name":"Christine Lukacs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christine M. Lukacs","raw_affiliation_strings":["Department of Discovery Technologies, Hoffmann-La Roche, Nutley, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Technologies, Hoffmann-La Roche, Nutley, NJ, USA","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054194996","display_name":"R. Ursula Kammlott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Ursula Kammlott","raw_affiliation_strings":["Department of Discovery Technologies, Hoffmann-La Roche, Nutley, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Technologies, Hoffmann-La Roche, Nutley, NJ, USA","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088408344","display_name":"A. Kuglstatter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andreas Kuglstatter","raw_affiliation_strings":["Department of Discovery Technologies, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Technologies, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007039813","display_name":"DAVID M. GOLDSTEIN","orcid":"https://orcid.org/0000-0003-1276-7623","observed_orcids":["https://orcid.org/0000-0003-1276-7623"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Goldstein","raw_affiliation_strings":["Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA 94304, USA","institution_ids":["https://openalex.org/I129302853"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.5035,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.79583533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"22","issue":"24","first_page":"7381","last_page":"7387"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.3118000030517578,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.16040000319480896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jnk-inhibitor","display_name":"JNK inhibitor","score":0.9330000281333923},{"id":"https://openalex.org/keywords/4-quinolones","display_name":"4-quinolones","score":0.9089999794960022},{"id":"https://openalex.org/keywords/jnk1-2","display_name":"JNK1/2","score":0.7490000128746033},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.8140000104904175},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.9649999737739563},{"id":"https://openalex.org/keywords/asthma-model","display_name":"asthma model","score":0.6470000147819519},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.5649999976158142},{"id":"https://openalex.org/keywords/compound-synthesis","display_name":"compound synthesis","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8099139928817749},{"id":"https://openalex.org/C2779922871","wikidata":"https://www.wikidata.org/wiki/Q426549","display_name":"Quinolone","level":3,"score":0.7631412148475647},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4949588179588318},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.4917645752429962},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4896603226661682},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.47871994972229004},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.46154525876045227},{"id":"https://openalex.org/C143724316","wikidata":"https://www.wikidata.org/wiki/Q312468","display_name":"Series (stratigraphy)","level":2,"score":0.45062097907066345},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.34134641289711},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2566562294960022},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1722739338874817},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.11876294016838074},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042462","descriptor_name":"4-Quinolones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D042462","descriptor_name":"4-Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D042462","descriptor_name":"4-Quinolones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2012.10.066","doi":"https://doi.org/10.1016/j.bmcl.2012.10.066","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.066","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23142618","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23142618","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W165372149","https://openalex.org/W1572174728","https://openalex.org/W1984052581","https://openalex.org/W1984903682","https://openalex.org/W1988500720","https://openalex.org/W1989116199","https://openalex.org/W1993351141","https://openalex.org/W1995536189","https://openalex.org/W2003013566","https://openalex.org/W2009165238","https://openalex.org/W2015351380","https://openalex.org/W2024264816","https://openalex.org/W2051664811","https://openalex.org/W2064119981","https://openalex.org/W2070463236","https://openalex.org/W2077414147","https://openalex.org/W2077713986","https://openalex.org/W2087774017","https://openalex.org/W2139410627","https://openalex.org/W2917141367","https://openalex.org/W2951909626","https://openalex.org/W3217178944","https://openalex.org/W4299920827"],"related_works":["https://openalex.org/W1979409471","https://openalex.org/W2085389945","https://openalex.org/W2001442235","https://openalex.org/W1987328619","https://openalex.org/W2917141367","https://openalex.org/W2015351380","https://openalex.org/W1988500720","https://openalex.org/W2951449008","https://openalex.org/W1981124072","https://openalex.org/W2065896045"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}